MINK THERAPEUTICS INC

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

06 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

30 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

20 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Reports Third Quarter 2023 Results

09 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023

03 ноя 2023 12:00:00 Источник Nasdaq GlobeNewswire

MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update

30 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023

27 сен 2023 09:05:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics to Participate in September Investor Conferences

24 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Reports Second Quarter 2023 Results

10 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire

MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update

28 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

05 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire

MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference

22 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

MiNK's Novel FAP-CAR-iNKT Presented at ASGCT

18 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results

11 май 2023 08:00:02 Источник Nasdaq GlobeNewswire

MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results

27 апр 2023 08:30:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting

18 апр 2023 13:32:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

21 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting

15 мар 2023 08:45:00 Источник Nasdaq GlobeNewswire

MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results

07 мар 2023 09:00:01 Источник Nasdaq GlobeNewswire

MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference

16 фев 2023 09:28:43 Источник Nasdaq GlobeNewswire